Balanced news tone
News Sentiment
CLBX sentiment intelligence
CelLBxHealth plc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-8.3% over one week, -22.5% over four weeks, trend active, and below fair value.
CelLBxHealth grants 50 million share options to employees By Investing.com
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
CelLBxHealth grants 50 million share options to employees By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 06:51
- Source
- Investing.com Canada
REG - CelLBxHealth PLC - Issue of Share Options
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 06:00
- Source
- TradingView
CelLBxHealth moves from cutting to converting
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 08:49
- Source
- Market source
CelLBxHealth plc Reports Earnings Results for the Half Year Ended June 30, 2026
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jul 2026 08:05
- Source
- marketscreener.com
Earnings Flash (CLBX.L) CelLBxHealth PLC Reports H1 Revenue GBP597,000
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jul 2026 06:07
- Source
- marketscreener.com
REG - CelLBxHealth PLC - Q2 and First Half Year Results ended 30 June 2026
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jul 2026 06:00
- Source
- TradingView
REG - CelLBxHealth PLC - Result of AGM
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 08:46
- Source
- TradingView
CelLBxHealth Reaffirms Growth Outlook as Search for New CEO Gets Underway (CLBX)
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 14 Jul 2026 07:17
- Source
- Market source
CelLBxHealth reaffirms revenue guidance
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 06:12
- Source
- Market source
REG - CelLBxHealth PLC - AGM Statement
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 06:00
- Source
- TradingView
CelLBxHealth CEO departs as board backs CTC growth strategy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 07 Jul 2026 16:02
- Source
- The Globe and Mail
Cellbxhealth plc Announces Resignation of Peter Collins as Chief Executive Officer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 21:06
- Source
- marketscreener.com
REG - CelLBxHealth PLC - Directorate change
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- TradingView
CelLBxHealth plc Announces Termination of Peter Michael Collins from Director, Effective July 6, 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- marketscreener.com
CelLBxHealth guides for higher 2026 revenue but loss widens
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Jun 2026 07:00
- Source
- marketscreener.com
CelLBxHealth Insider Confidence Rewarded, Stock Hits UK£24m Market Cap
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 May 2026 07:00
- Source
- Market source
CelLBxHealth strikes AstraZeneca services deal for CTC-powered analytics
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 30 May 2026 07:00
- Source
- The Globe and Mail
CelLBxHealth shares jump 36% after master services agreement with AstraZeneca
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- Proactive Investors
CelLBxHealth shares jump on partnership with AstraZeneca
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 29 May 2026 07:00
- Source
- London South East
CelLBxHealth enters service agreement with AstraZeneca, shares pop
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- Sharecast.com
CelLBxHealth secures AstraZeneca agreement to provide circulating tumour cell analytics services (CLBX)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- Market source
CelLBxHealth shares jump on forecast for 50% revenue growth in 2026
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- London South East
CelLBxHealth (CLBX) Accelerates Cost Reduction Programme and Targets Stronger 2026 Revenue Growth
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
CelLBxHealth shares jump 17% as strategic deals and cost reset lift sentiment
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- Market source
Cavendish sees Royal Marsden tie-up as key validation step for CelLBxHealth's liquid biopsy platform
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Apr 2026 07:00
- Source
- Market source
Cellbxhealth Plc ORD GBP0.05 share price | CLBX
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Dec 2025 20:35
- Source
- Hargreaves Lansdown
CelLBxHealth PLC Share Price - CLBX, RNS News, Articles, Quotes, & Charts (LON:CLBX)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Oct 2025 03:54
- Source
- Proactive Investors
CLBX Stock Price and Chart — LSE:CLBX
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Oct 2025 20:21
- Source
- TradingView